Abstract

Chronic beta-adrenergic blockade prevents volume overload-induced re-localization and oxidation of soluble guanylyl cyclase

Highlights

  • While b-adrenergic blockade is a cornerstone of heart failure therapy, its therapeutic role in chronic mitral regurgitation remains questionable

  • Expression, localization, cyclase activity, and redox state of myocardial soluble guanylyl cyclase (sGC) were assessed in Control, mitral regurgitation (MR), and MR+bB dogs

  • * Correspondence: emily.tsai@tuhs.temple.edu 1Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA, 19140, USA Full list of author information is available at the end of the article total sGCa1 expression fell to nearly 50% of Control and re-localized away from Cav3+LR to non-lipid raft microdomains (NLR)

Read more

Summary

Introduction

While b-adrenergic blockade is a cornerstone of heart failure therapy, its therapeutic role in chronic mitral regurgitation remains questionable. Materials and methods Volume-overload (VO) was established by chordal ruptureinduced mitral regurgitation (MR) in mongrel dogs. Some dogs were treated with metoprolol succinate (100mg orally once daily; MR+ bB).

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.